Gilead Sciences, Inc.
GILD
$96.91
-$1.25-1.27%
NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 1,129.90% | -91.53% | -97.86% | -80.78% | -91.31% |
| Total Depreciation and Amortization | 1.09% | 2.75% | 9.04% | 16.09% | 23.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -58.76% | 333.68% | 451.89% | 315.82% | 222.39% |
| Change in Net Operating Assets | 34.50% | 61.79% | -16.01% | -1,841.71% | -94.23% |
| Cash from Operations | 22.23% | 35.25% | 19.25% | -21.49% | -5.51% |
| Capital Expenditure | 10.15% | 10.60% | -7.26% | 2.39% | 1.53% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 76.96% | -320.14% | -362.33% | -211.85% | -201.36% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -104.12% | 462.50% | 721.40% | 571.51% | 1,835.16% |
| Cash from Investing | 54.55% | -52.27% | -106.53% | -44.76% | -64.09% |
| Total Debt Issued | 74.95% | 74.95% | -99.95% | -- | -- |
| Total Debt Repaid | -65.87% | 12.44% | 12.76% | -310.10% | -125.00% |
| Issuance of Common Stock | 87.90% | 81.90% | -28.01% | -22.39% | -9.94% |
| Repurchase of Common Stock | -48.00% | -15.00% | 42.14% | 37.58% | 30.75% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -2.82% | -2.86% | -2.83% | -2.69% | -2.60% |
| Other Financing Activities | -30.27% | -1.08% | 0.37% | -11.91% | -20.83% |
| Cash from Financing | -8.23% | 33.01% | -21.72% | -12.19% | 16.46% |
| Foreign Exchange rate Adjustments | -111.54% | -170.18% | -45.26% | -93.10% | 181.25% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | 200.00% |
| Net Change in Cash | 1,571.56% | 480.39% | -166.50% | -403.83% | -134.06% |